NeuroCytonix Inc, is an emerging biotechnology company founded in January 2017 to develop and exploit disruptive medical technologies for regeneration of the nervous system. NEUROCYTONIX has developed a new technology that we have found to be effective in treating patients suffering from Cerebral Palsy, Stroke, Traumatic Brain Injury(TBI) related neurological consequences and Covid 19 neurological issues in brief non degenerative brain diseases. Please see www.neurocytonix.com for more information on our company based in Rockville MD.